INTRODUCTION
Human immunodeficiency virus (HIV) is a member of genus lentivirus, and like all viruses of this type, it attacks the immune system. Lentiviruses are in turn, part of the family of viruses known as retroviridae. They have been found in a number of different animals, including cats, sheep, horses and cattle. However, the most interesting lentivirus in terms of the investigation into the origins of HIV is the simian immunodeficiency virus (SIV) that affects monkeys. It is now generally accepted that HIV is a descendant of a simian immunodeficiency virus because certain strains of SIV bear a very close resemblance to HIV-1 and HIV-2, the two types of HIV. [1] [2] [3] The prevalence of infection with HIV is increasing, particularly in the developing world and many people are unaware of their infections. 4 The center for disease control and prevention (CDC) recommends that persons with ongoing risks be retested for HIV periodically. Many people who are at risk are not tested for HIV. 5 Recently, several products that afford different options for antibody testing have become commercially available. Some of these testing options are for use by the individual at home; others are for use in clinics, for example self-laceration blood drip collection kit, and also some using urine and saliva. Tamshiro and Constantine (1994) found a test that detects HIV antibody in urine specimens. 6 Saliva is a mixture of secretion from the salivary glands and transudate from the capillaries beneath the buccal mucosa, the so-called crevicular fluid that constantly flows from the crevice between the gum margin and the teeth. It is known that saliva contains secretory IgA (sIgA), but until recently little attention has been given to the presence of other classes of immunoglobulins in saliva. The contents of the crevicular fluid are similar to plasma, and include significant amounts of antibodies specific to those viruses to which the subject has already made, or is making a humoral response. The HIV antibody found in saliva is mainly IgG, which is locally added to saliva from crevicular fluid. Since, immunoglobulin concentrations in crevicular fluid are much higher than in JIAOMR salivary gland secretions, the investigator collecting the salivary sample must ensure that the crevicular fluid is included in specimen in a sufficient amount. Substantial amounts of crevicular fluid must be represented in the salivary sample, particularly when IgG and IgM are to be detected. 7 It has now been shown that antibodies to HIV from the oral cavity can be detected with a sensitivity and specificity that are essentially identical to those of tests with serum. The use of saliva in reference methods has now become equally feasible, when such protocols are appropriately modified. [8] [9] [10] The objectives of our study were to detect the antibody to human immunodeficiency virus in saliva and to compare the presence of antibody to human immunodeficiency virus in saliva and serum, thus assessing the usefulness of saliva in diagnosing HIV status of an individual.
MATERIALS AND METHODS
A comparative randomized study was conducted at Dayananda Sagar College of Dental Sciences, Bangaluru, and HIV unit, Kempegowda Institute of Medical Sciences (KIMS) and Hospital. Study was approved by the institutional review board. The study consisted of two groups: Study group and control group. Study consisted of 80 patients (40 HIV-positive in study group and 40 HIV-negative patients in control group) above 2 years of age chosen randomly. Known HIV-positive patients were selected randomly from the HIV unit of Kempegowda Hospital and Controls (HIV-negative patients) were randomly selected from Dayananda Sagar College of Dental Sciences and KIMS Hospital.
Paired serum and saliva samples were collected from the case and control subjects. Written informed consent was obtained from all the participants. Blood specimens were obtained by venepuncture by a trained professional under standardized sterilization protocol. Unstimulated whole saliva was collected from both cases and controls as per the stipulated procedure ( Fig. 1 ). Serum samples were analyzed for HIV antibody at Kempegowda Hospital by enzyme-linked immunosorbitol assay (ELISA) methods as per National AIDS Control Organization (NACO) guidelines. Saliva samples were analyzed using Calypte Aware HIV-1/2 OMT test kit (Fig. 2) . Salivary test was interpreted as reactive, nonreactive or invalid. Salivary test was considered as reactive when two lines appear, i.e. two lines on the test strip, in the test zone and control zone respectively (Fig. 3A) . A reactive result indicated that anti-HIV-1 or 2 antibodies have been detected in the specimen. Salivary test was considered as nonreactive when only the control line appears (Fig. 3B) . It suggests the absence of reactive anti-HIV antibodies in the specimen. The results were tabulated and subjected to statistical analysis using Chi-square test.
RESULTS
Eighty patients were divided into two groups: Study group consisting of 40 HIV-positive patients and control group consisting of 40 HIV-negative patients. Out of 80 patients, 53 were male and 37 were female. Study group consisted of 18 males and 22 females. The control group consisted of 15 female and 25 male patients ( Table 1 ). The mean age of these patients ranged from 22 to 58 years in study group and 20 to 55 years in control group (Table 2) .
A B
Study group had 40 HIV-positive patients. These 40 patients were tested for presence of antibodies in saliva, 39 patients showed 'reactive' results, that is, 39 patients who were actually HIV positive were detected to have antibodies in saliva. Out of 40 patients, one patient who had antibody in serum 'reactive' was tested to be nonreactive in saliva, that is, there was no antibody detected in saliva (Table 3 , Graph 1).
Control group had 40 HIV-negative patients. Their status was confirmed by ELISA method and inferred as 'nonreactive' to HIV antibody in serum. All the 40 of the control group when tested for presence of antibodies in saliva, showed 'nonreactive' results, that is, 40 patients who were actually HIV negative in serum, did not have antibodies to HIV in saliva as well (Table 4 and Graph 2).
The sensitivity of saliva test was found to be 97.50% and the specificity was found to be 100% ( Table 5 ). The positive predictive value of saliva test was found to be 100% and the negative predictive value was found to be 97.56% (Table 6 ).
DISCUSSION
In our study, out of 40 patients, 39 had antibodies to HIV in saliva. This means that only one patient who was seropositive for HIV was detected as HIV nonreactive in saliva. This correlated with the studies conducted by Miguel Urquia et al (1993) 11 in which there were 50 HIV-seropositive patient and 50 HIV-negative patients, and 46 subjects were tested positive in saliva. This also correlated with study conducted by However, in the studies that were conducted by DW Archibald et al (1986) 14 showed that only 28 of 35 HIV-positive patients had antibodies to HIV in saliva, that is, this study showed slightly lower specificity as compared to our study. This could be because improvised technique that was used in our study. 
JIAOMR
One case in our study showed false-negative results. The saliva test was repeated for the same patient using a new kit after 20 minutes. But the results were false negative again. In order to know, what could have gone wrong, we conducted Western blot test for the saliva of the same patient along with the serum of the patient (Fig. 4) . Reasons for this could be many, such as low antibody titers present in saliva, which could be reduced even more as a result of the immunodeficient state in AIDS (Archibald et al 1986). 14 The salivary antibody levels may drop as salivary viral levels drop. Considering that salivary IgG level is 1/80th as much potential antibody as compared with total serum levels, fall in viral load could have contributed to low antibody titer in saliva which led to false-negative result in one patient.
14,15 Richard S Ferri (1998) found that the microflora occurring in the oral cavity degrades antibodies in saliva, contributing to the destabilization of the sample. 16 Study by Robert M Grant et al (1996) have shown that mean beta-2 microglobulin levels were lower in patients with false-negative saliva tests than in patients with true-positive saliva tests. 17 However, we did not test to detect beta-2 macroglobulin levels in our patient with falsenegative report in saliva.
Timothy C Granade et al (1995) 18, 19 used oral fluid collected with Omni-Sal as a specimen for detection and confirmation of antibodies to HIV type I and compare the results with those for matched serum samples. Oral fluids were analyzed using three enzyme immunoassays (EIAs): GACELISA, a research use only kit from Organon Teknika Corporation, and the Abbott 3A11 EIA. Results of ELISA showed 100% sensitivity for all the three ELISAs and specificity were 89.6% for the Abbott 3A11 EIA, 96.5% for the GACELISA, and 97.8% for the Organon Teknika Corporation EIA. However, our study showed different results. Our study showed a sensitivity of 97.50% and specificity of 100%, indicating our study had higher specificity as compared to the study conducted by Timothy C Granade et al (1995) . This could be because the analysis of oral fluid was done modifying reagents that were used for serum in their study. But the kit that is used in our study is exclusively for oral fluid which has led to higher specificity. The lower sensitivity in our study as compared to the study conducted by Timothy C Granade et al (1995) could be attributed to lower sample size in our study as compared to their study (their sample size was 287 patients). Their study used Omni-Sal for saliva collection which had an indicator for optimum saliva collection. The saliva collecting device in our study did not have such facility, so the saliva collection in the false-negative case in our study might have been inappropriate. RL Hondika et al (1998) 20 conducted a study to assess the usefulness of saliva and other oral fluids for the detection of HIV antibodies and also compare devices employed for specimen collection, and analyze the reliability and accuracy of performing HIV antibody tests on oral secretions compared to serum or plasma. He used several saliva collecting devices, such as Salivette, Orapette, Omni-Sal and OraSure. The mean sensitivities of oral-fluid-based screening for HIV antibody were reported to be 95.2% for whole saliva compared with 98.6% for OraSure, 98.1% for Omni-Sal and 97.9% for Salivette. The mean specificities of HIV screening tests with oral-fluid samples were uniformly high: 99.0% for whole saliva, 99.9% for OraSure, 99.7% for Omni-Sal and 98.0% for Salivette. Our study showed similar results with sensitivity of 97.50% and but better specificity of 100%. In our study saliva was collected using oral fluid collecting swab provided in Calypte Aware HIV-1/2 OMT test kit. This has a certain advantage as compared to other saliva collecting instruments, such as Omni-Sal. Our oral fluid collecting swab collected saliva from the gumlines as compared to Omni-Sal which collected mainly saliva from the underside of the tongue.
In our study, the positive predictive value of saliva test was found to be 97.50% and the negative predictive value was found to be 100%. This correlated with the study conducted by Adonsou et al (1998) 21 who found positive and negative predictive value of 99.7 and 98.7% in their study.
CONCLUSION
On the basis of our study, we conclude that saliva is a oral fluid containing antibodies of diagnostic significance, which can be collected readily, conveniently, and with minimal hazards as compared to venepuncture. Many immunosensitive assays are available now, making saliva as diagnostic tool, which can detect antibodies in a very minute quantity. The salivary testing provides the comfort of being able to perform in a dental office and also allows testing in broader front like in children, hardto-reach risk groups and in epidemiological studies. If the salivary test is positive, patients can be referred to healthcare providers for counseling and additional diagnostic blood tests. Since, salivary testing has high accuracy, feasibility and client preference, it should be made affordable in resource limited countries which need them the most.
